These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19146417)

  • 1. The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.
    Wroblowski B; Wigglesworth MJ; Szekeres PG; Smith GD; Rahman SS; Nicholson NH; Muir AI; Hall A; Heer JP; Garland SL; Coates WJ
    J Med Chem; 2009 Feb; 52(3):818-25. PubMed ID: 19146417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of small molecule antagonists of the human mas-related gene-X1 receptor.
    Kunapuli P; Lee S; Zheng W; Alberts M; Kornienko O; Mull R; Kreamer A; Hwang JI; Simon MI; Strulovici B
    Anal Biochem; 2006 Apr; 351(1):50-61. PubMed ID: 16510108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of small molecule agonists of the motilin receptor.
    Heightman TD; Conway E; Corbett DF; Macdonald GJ; Stemp G; Westaway SM; Celestini P; Gagliardi S; Riccaboni M; Ronzoni S; Vaidya K; Butler S; McKay F; Muir A; Powney B; Winborn K; Wise A; Jarvie EM; Sanger GJ
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6423-8. PubMed ID: 18980843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis.
    Malik L; Kelly NM; Ma JN; Currier EA; Burstein ES; Olsson R
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1729-32. PubMed ID: 19230660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonists.
    Habashita H; Kokubo M; Hamano S; Hamanaka N; Toda M; Shibayama S; Tada H; Sagawa K; Fukushima D; Maeda K; Mitsuya H
    J Med Chem; 2006 Jul; 49(14):4140-52. PubMed ID: 16821774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives.
    Imai M; Shiota T; Kataoka K; Tarby CM; Moree WJ; Tsutsumi T; Sudo M; Ramirez-Weinhouse MM; Comer D; Sun CM; Yamagami S; Tanaka H; Morita T; Hada T; Greene J; Barnum D; Saunders J; Myers PL; Kato Y; Endo N
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5407-11. PubMed ID: 15454235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist.
    Lund BW; Piu F; Gauthier NK; Eeg A; Currier E; Sherbukhin V; Brann MR; Hacksell U; Olsson R
    J Med Chem; 2005 Dec; 48(24):7517-9. PubMed ID: 16302793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of pyridazinone-based 5-HT(2C) agonists.
    Allerton CM; Andrews MD; Blagg J; Ellis D; Evrard E; Green MP; Liu KK; McMurray G; Ralph M; Sanderson V; Ward R; Watson L
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5791-5. PubMed ID: 19716297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
    Nakajima Y; Imanishi M; Itou S; Hamashima H; Tomishima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Hattori K
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5037-40. PubMed ID: 18752946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
    Pinard E; Alberati D; Borroni E; Fischer H; Hainzl D; Jolidon S; Moreau JL; Narquizian R; Nettekoven M; Norcross RD; Stalder H; Thomas AW
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5134-9. PubMed ID: 18752953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: discovery of the dihydropyridazinone motif.
    Ujjainwalla F; Warner D; Snedden C; Grisson RD; Walsh TF; Wyvratt MJ; Kalyani RN; Macneil T; Tang R; Weinberg DH; Van der Ploeg L; Goulet MT
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4023-8. PubMed ID: 16005624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes.
    Bharate SB; Nemmani KV; Vishwakarma RA
    Expert Opin Ther Pat; 2009 Feb; 19(2):237-64. PubMed ID: 19441920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.
    Cole AG; Stroke IL; Qin LY; Hussain Z; Simhadri S; Brescia MR; Waksmunski FS; Strohl B; Tellew JE; Williams JP; Saunders J; Appell KC; Henderson I; Webb ML
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5420-3. PubMed ID: 18815029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a potent and novel motilin agonist.
    Li JJ; Chao HG; Wang H; Tino JA; Lawrence RM; Ewing WR; Ma Z; Yan M; Slusarchyk D; Seethala R; Sun H; Li D; Burford NT; Stoffel RH; Salyan ME; Li CY; Witkus M; Zhao N; Rich A; Gordon DA
    J Med Chem; 2004 Mar; 47(7):1704-8. PubMed ID: 15027861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives.
    Saku O; Ohta K; Arai E; Nomoto Y; Miura H; Nakamura H; Fuse E; Nakasato Y
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1053-7. PubMed ID: 18160288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of a G-protein-coupled receptor antagonist library of aryloxyalkanolamines using a polymer-supported acyclic acetal linker.
    Roberge JY; Harikrishnan LS; Kamau MG; Ruan Z; Van Kirk K; Liu Y; Cooper CB; Poss MA; Dickson JK; Gavai AV; Chao ST; Leith LW; Bednarz MS; Mathur A; Kakarla R; Schnur DM; Vaz R; Lawrence RM
    J Comb Chem; 2009; 11(1):72-82. PubMed ID: 19086798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of aequorin for G protein-coupled receptor hit identification and compound profiling.
    Brough SJ; Shah P
    Methods Mol Biol; 2009; 552():181-98. PubMed ID: 19513650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist.
    Lim HD; Smits RA; Bakker RA; van Dam CM; de Esch IJ; Leurs R
    J Med Chem; 2006 Nov; 49(23):6650-1. PubMed ID: 17154494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity.
    Berardi F; Abate C; Ferorelli S; de Robertis AF; Leopoldo M; Colabufo NA; Niso M; Perrone R
    J Med Chem; 2008 Dec; 51(23):7523-31. PubMed ID: 19053780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.